Home › Funds › Caligan Partners LP › ARTV
Caligan Partners LP position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Caligan Partners LP reported holding 1,736,111 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$16.8M, representing 0.98% of its reported portfolio and ranking #20 among its reported holdings. Caligan Partners LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's ARTV position evolved
Caligan Partners LP first disclosed a stake in ARTV in Q2 2026 at 1,736,111 shares (US$16.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.74M | $16.84M | New |
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K sh · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K sh · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K sh · $5.09M · Q2 2026
- Revelation Capital Management, LLC 299.31K sh · $2.90M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M · Q2 2026
- KVP Capital Advisors, LP 200.00K sh · $1.94M · Q2 2026
- Velan Capital Investment Management LP 25.00K sh · $242.50K · Q2 2026
- Spark Investment Management LLC 16.50K sh · $160.05K · Q2 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held ARTV?
Caligan Partners LP has disclosed ARTV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Caligan Partners LP's current position in ARTV?
As of Q2 2026, Caligan Partners LP holds 1.74M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $16.84M, representing 0.98% of its reported portfolio and ranking #20.
Has Caligan Partners LP been buying or selling ARTV?
In the latest 13F filing (Q2 2026), Caligan Partners LP newly opened its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.